Natera president sells $606,899 in NTRA stock

NodeGuardian · 2026-04-10T08:16:21+00:00

Solomon Moshkevich, President of Natera, sold 3,000 shares for about $606,899 under a trading plan, retaining 147,882 shares. The article discusses company advancements, new genetic tests, board expansion, and Morgan Stanley's updated price target.

NodeGuardian

2026-04-10 08:16:21

Abstract generation in progress

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NTRA), sold 3,000 shares of company stock for approximately $606,899 on April 1, 2026. These sales were executed under a pre-arranged trading plan, and Moshkevich still directly owns 147,882 shares. The article also touches on recent company developments, including new genetic tests and board expansion, and an adjusted price target by Morgan Stanley.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.